Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

Performance improvements of stool-based screening tests.

van Dam L, Kuipers EJ, van Leerdam ME.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):479-92. doi: 10.1016/j.bpg.2010.03.009. Review.

PMID:
20833351
2.

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.

Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME.

Br J Cancer. 2009 Apr 7;100(7):1103-10. doi: 10.1038/sj.bjc.6604961.

3.
4.

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.

Tinmouth J, Lansdorp-Vogelaar I, Allison JE.

Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3. Review.

PMID:
26041750
6.

New stool screening tests for colorectal cancer.

Young GP, Cole S.

Digestion. 2007;76(1):26-33. Epub 2007 Oct 19. Review.

PMID:
17947816
7.

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ.

Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Epub .

PMID:
19671542
8.

Colon cancer screening: which non-invasive filter tests?

Pox C.

Dig Dis. 2011;29 Suppl 1:56-9. doi: 10.1159/000331127. Epub 2011 Nov 15. Review.

PMID:
22104755
9.

Practical advances in stool screening for colorectal cancer.

Potack J, Itzkowitz SH.

J Natl Compr Canc Netw. 2010 Jan;8(1):81-92. Review.

PMID:
20064291
10.

Sex differences in performance of fecal occult blood testing.

Brenner H, Haug U, Hundt S.

Am J Gastroenterol. 2010 Nov;105(11):2457-64. doi: 10.1038/ajg.2010.301. Epub 2010 Aug 10.

PMID:
20700114
11.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
12.

Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.

Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G, Guittet L.

Int J Cancer. 2015 Apr 15;136(8):1827-34. doi: 10.1002/ijc.29187. Epub 2014 Sep 18.

13.

Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.

Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ.

Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4.

PMID:
20621736
14.

Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.

Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ.

Aliment Pharmacol Ther. 2010 Feb 1;31(3):432-9. doi: 10.1111/j.1365-2036.2009.04184.x. Epub 2009 Oct 29.

15.

Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.

Fraser CG, Digby J, McDonald PJ, Strachan JA, Carey FA, Steele RJ.

J Med Screen. 2012 Mar;19(1):8-13. doi: 10.1258/jms.2011.011098. Epub 2011 Dec 7.

PMID:
22156144
16.
17.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

18.

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

Hundt S, Haug U, Brenner H.

Ann Intern Med. 2009 Feb 3;150(3):162-9.

PMID:
19189905
19.

A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, Chan CK, Lam SK.

Aliment Pharmacol Ther. 2003 Nov 1;18(9):941-6.

20.

Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.

Birkenfeld S, Belfer RG, Chared M, Vilkin A, Barchana M, Lifshitz I, Fruchter D, Aronski D, Balicer R, Niv Y, Levi Z.

J Med Screen. 2011;18(3):135-41. doi: 10.1258/jms.2011.010147.

PMID:
22045822
Items per page

Supplemental Content

Write to the Help Desk